News Category
Oncotelic Therapeutics announced that its Phase 1b trial of Sapu003 cleared initial safety review with no dose-limiting toxicities, advancing to the n...
GeoVax Labs has appointed three immuno-oncology experts to its new Oncology Advisory Board to advance its Gedeptin gene-directed enzyme prodrug therap...
